Lee Maria, Cullen Alexis E, Matheson Granville J, Lu Zheng-An, Bergen Sarah E, Sellgren Carl M, Erhardt Sophie, Fatouros-Bergman Helena, Cervenka Simon
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Sweden.
Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Schizophr Res Cogn. 2025 Aug 29;42:100387. doi: 10.1016/j.scog.2025.100387. eCollection 2025 Dec.
Cognitive dysfunction is a core feature of psychotic disorders. The degree of impairment varies greatly between individuals, which may reflect different levels of decline from pre-morbid functioning. Diverse trajectories of cognitive change prior to or during development of psychosis have been hypothesized to reflect distinct underlying pathological processes. Our primary aim was to model cognitive change over time in a sample of individuals with first-episode psychosis (FEP) and controls. The secondary aim was to explore associations between cognitive change, clinical outcomes and select biological markers.
Our sample consisted of 72 individuals with FEP and 53 controls. School grades from nationwide population registers were used as a proxy for pre-morbid cognitive ability. All participants underwent formal cognitive testing at psychosis onset, with a subset returning for testing at 1,5 year follow up. Cognitive change was modelled using linear mixed-effects models, and resulting change scores were correlated to polygenic risk scores, cerebrospinal fluid levels of complement protein C4A and clinical outcomes.
Groups did not differ in school performance prior to psychosis. Psychosis onset was associated with marked cognitive decline in FEP individuals, who subsequently performed significantly worse than controls. However, cognitive change over time varied widely between FEP individuals. Degree of cognitive change was not associated with the selected biological variables but did predict worse clinical outcomes.
Individual cognitive trajectories may be a clinically relevant topic for further study, and larger studies are needed to further explore their potential role in stratified models of care.
认知功能障碍是精神障碍的核心特征。个体之间的损害程度差异很大,这可能反映了病前功能衰退的不同水平。有人推测,在精神病发展之前或期间,认知变化的不同轨迹反映了不同的潜在病理过程。我们的主要目的是对首发精神病(FEP)患者和对照组个体的认知随时间的变化进行建模。次要目的是探讨认知变化、临床结局与选定生物标志物之间的关联。
我们的样本包括72名FEP患者和53名对照组。全国人口登记处的学校成绩被用作病前认知能力的替代指标。所有参与者在精神病发作时都接受了正式的认知测试,其中一部分在1.5年随访时返回进行测试。使用线性混合效应模型对认知变化进行建模,并将所得变化分数与多基因风险分数、脑脊液补体蛋白C4A水平和临床结局相关联。
精神病发作前两组在学业表现上没有差异。精神病发作与FEP患者明显的认知衰退相关,这些患者随后的表现明显比对照组差。然而,FEP患者之间认知随时间的变化差异很大。认知变化程度与选定的生物变量无关,但确实预示着更差的临床结局。
个体认知轨迹可能是一个值得进一步研究的临床相关课题,需要更大规模的研究来进一步探索它们在分层护理模式中的潜在作用。